We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
-2.65%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$4.16M
Cap. Flow
+$9.37M
Cap. Flow %
6.12%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$7.47M
2
PHVS icon
Pharvaris
PHVS
+$1.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
1
Pharvaris
PHVS
$2.28B
$81.4M 53.23%
4,397,881
+104,027
+2% +$1.9M
KURA icon
2
Kura Oncology
KURA
$800M
$36.1M 23.62%
1,849,947
– –
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.69B
$16.8M 11.01%
875,000
– –
LYEL icon
4
Lyell Immunopharma
LYEL
$317M
$11.5M 7.51%
416,250
– –
RLAY icon
5
Relay Therapeutics
RLAY
$4.1B
$7.08M 4.63%
+1,000,000
New +$7.47M

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q3 2024 Portfolio in Review

As of Q3 2024, Foresite Capital Management IV held 5 positions worth $153M, up 2.8% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management IV deployed $9.37M of net new capital in Q3 2024, opening 1 new position and adding to 1 existing holding. Its largest new stake was Relay Therapeutics: 1,000,000 shares worth $7.08M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management IV's largest Q3 2024 buy was Relay Therapeutics: 1,000,000 shares worth $7.08M.
  • Foresite Capital Management IV added most to Pharvaris in Q3 2024, an estimated $1.9M increase.
  • Foresite Capital Management IV's ten largest holdings make up 100% of its $153M portfolio in Q3 2024.
  • Foresite Capital Management IV opened 1 new position and closed 0 in Q3 2024.
  • Foresite Capital Management IV's portfolio value rose 2.8% quarter-over-quarter to $153M.

Based on Foresite Capital Management IV's 13F filing for Q3 2024, filed 14 Nov 2024.